ERBB2 and urinary bladder cancer: In the largest single-center HER-2 study in UTUC patients (32), Sasaki et al. investigated HER-2 status in 171 UTUC patients who underwent RNU and found that overexpression and amplification of HER-2 was associated with early bladder cancer recurrence.